Layered silicate nanoparticles as a non-injectable drug delivery system for biomacromoleculesJOURNAL OF PHARMACEUTICAL INVESTIGATIONIF5.12024-04-235PRE
Organic clay-based fast dissolving microneedles for efficient transdermal delivery of therapeutic proteinsJOURNAL OF PHARMACEUTICAL INVESTIGATIONIF5.12024-02-140PRE
Improved Therapeutic Efficacy of MT102, a New Anti-Inflammatory Agent, via a Self-Microemulsifying Drug Delivery System, in Ulcerative Colitis MicePHARMACEUTICSIF5.52023-12-021OAAI
Fabrication and Evaluation of a pH-Responsive Nanocomposite-Based Colonic Delivery System for Improving the Oral Efficacy of LiraglutideINTERNATIONAL JOURNAL OF NANOMEDICINEIF6.52023-07-013OAAI
Quantitative analysis of therapeutic proteins in biological fluids: recent advancement in analytical techniquesDRUG DELIVERYIF8.12023-03-0615OA
Aminoclay Nanoparticles Induce Anti-Inflammatory Dendritic Cells to Attenuate LPS-Elicited Pro-Inflammatory Immune ResponsesMOLECULESIF4.62022-12-096OAAI
Site-selective oral delivery of therapeutic antibodies to the inflamed colon via a folic acid-grafted organic/inorganic hybrid nanocomposite systemACTA PHARMACEUTICA SINICA BIF14.62022-11-0114OAAI
Lipid/Clay-Based Solid Dispersion Formulation for Improving the Oral Bioavailability of CurcuminPHARMACEUTICSIF5.52022-10-2410OAAI
Enhanced Oral Bioavailability of MT-102, a New Anti-inflammatory Agent, via a Ternary Solid Dispersion FormulationPHARMACEUTICSIF5.52022-07-2110OAAI
Functional ligands for improving anticancer drug therapy: current status and applications to drug delivery systemsDRUG DELIVERYIF8.12022-06-2888OA
Development of an M cell targeted nanocomposite system for effective oral protein delivery: preparation, in vitro and in vivo characterizationJOURNAL OF NANOBIOTECHNOLOGYIF12.62021-01-0929OAAI
DK-1108 exerts anti-inflammatory activity against phorbol 12-myristate 13-acetate-induced inflammation and protective effect against OVA-induced allergic asthmaBIOMEDICINE & PHARMACOTHERAPYIF7.52020-12-0110OAAI
Enhanced oral delivery of insulin via the colon-targeted nanocomposite system of organoclay/glycol chitosan/Eudragit(R)S100JOURNAL OF NANOBIOTECHNOLOGYIF12.62020-07-2529OAAI
Ternary nanocomposite carriers based on organic clay-lipid vesicles as an effective colon-targeted drug delivery system: preparation and in vitro/in vivo characterizationJOURNAL OF NANOBIOTECHNOLOGYIF12.62020-01-2136OAAI
Development of pH-responsive organic-inorganic hybrid nanocomposites as an effective oral delivery system of protein drugsJOURNAL OF CONTROLLED RELEASEIF11.52019-10-0144PREAI
Development of a Ternary Solid Dispersion Formulation of LW6 to Improve the In Vivo Activity as a BCRP Inhibitor: Preparation and In Vitro/In Vivo CharacterizationPHARMACEUTICSIF5.52019-05-0123OAAI
Enhanced oral absorption of sorafenib via the layer-by-layer deposition of a pH-sensitive polymer and glycol chitosan on the liposomeINTERNATIONAL JOURNAL OF PHARMACEUTICSIF5.22018-06-0156PREAI
Biophysical evaluation of aminoclay as an effective protectant for protein stabilization during freeze-drying and storageINTERNATIONAL JOURNAL OF NANOMEDICINEIF6.52016-12-010OAAI